Literature DB >> 29578489

REM Sleep Behavior Disorder and Alzheimer's Disease: Definitely No Relationship?

Andrea Galbiati1,2, Giulia Carli1, Michael Hensley3, Luigi Ferini-Strambi1,2.   

Abstract

Rapid eye movement (REM) sleep behavior disorder (RBD) is a REM sleep parasomnia characterized by the loss of the typical muscular atonia present during healthy REM sleep. RBD can occur in the absence of other neurological conditions or in association with a neurodegenerative disorder. It is now well established that RBD is a strong predictor of neurodegeneration, in particular synucleinopathies, such as Parkinson's disease, Lewy body dementia (LBD), or multiple system atrophy. However, some longitudinal studies report that a minority of patients develop either overlapping form of dementia or Alzheimer disease's (AD). Although AD is reported as a possible development in patients with RBD, it is in a limited number of cases and there are concerns about the accuracy of the diagnostic criteria. Neuropsychological impairments identified in cross-sectional studies of RBD patients describe a profile similar to that observed in dementia related to synucleinopathies. However, only deficits in executive function predict the development of neurodegeneration. Longitudinal studies reported the development of AD in RBD patients in about 7% of cases with variability ranging from 3% and 11%. Since the majority of longitudinal investigations do not report AD as a possible development for RBD patients the proportion may be overestimated. The study of the relationship between RBD and AD may be confounded by two factors that lead to misdiagnosis: the use of clinical criteria alone and the overlap between the clinical features and neuropathology of AD and LBD. Future studies to investigate this association must use updated diagnostic criteria incorporating ancillary investigations.

Entities:  

Keywords:  Alzheimer’s disease; REM sleep behavior disorder; cognition; neurodegeneration

Mesh:

Year:  2018        PMID: 29578489     DOI: 10.3233/JAD-171164

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  7 in total

Review 1.  Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.

Authors:  Chanung Wang; David M Holtzman
Journal:  Neuropsychopharmacology       Date:  2019-08-13       Impact factor: 7.853

2.  Smaller pineal gland is associated with rapid eye movement sleep behavior disorder in Alzheimer's disease.

Authors:  Jeongbin Park; Seung Wan Suh; Grace Eun Kim; Subin Lee; Jun Sung Kim; Hye Sung Kim; Seonjeong Byun; Jong Bin Bae; Jae Hyoung Kim; Sang Eun Kim; Ji Won Han; Ki Woong Kim
Journal:  Alzheimers Res Ther       Date:  2020-11-21       Impact factor: 6.982

3.  Characteristics of Cortical Atrophy and White Matter Lesions Between Dementia With Lewy Bodies and Alzheimer's Disease: A Case-Control Study.

Authors:  Han Zhu; Hao Lu; Fei Wang; Shuai Liu; Zhihong Shi; Jinghuan Gan; Xiaoshan Du; Yaqi Yang; Daibin Li; Lichen Wang; Yong Ji
Journal:  Front Neurol       Date:  2022-01-11       Impact factor: 4.003

4.  Trauma Immediately Preceding REM-Behavior Disorder: A Valuable Prognostic Marker?

Authors:  Stevie R Williams; Nelly Henzler; Pavla Peřinová; Ian A Morrison; Jason G Ellis; Renata L Riha
Journal:  Front Neurol       Date:  2021-11-24       Impact factor: 4.003

Review 5.  Sleep deficiency as a driver of cellular stress and damage in neurological disorders.

Authors:  Rochelle L Coulson; Philippe Mourrain; Gordon X Wang
Journal:  Sleep Med Rev       Date:  2022-02-26       Impact factor: 11.401

6.  Molecular mechanism of tumour necrosis factor alpha regulates hypocretin (orexin) expression, sleep and behaviour.

Authors:  Shuqin Zhan; Pulin Che; Xue-Ke Zhao; Ning Li; Yan Ding; Jianghong Liu; Spring Li; Karyn Ding; Lynn Han; Zhaoyang Huang; Liyong Wu; Yuping Wang; Meng Hu; Xiaosi Han; Qiang Ding
Journal:  J Cell Mol Med       Date:  2019-08-06       Impact factor: 5.310

7.  Shift-work-related sleep disruption and the risk of decline in cognitive function: The CRUISE Study.

Authors:  Jana Thomas; Sebastiaan Overeem; Martin Dresler; Roy P C Kessels; Jurgen A H R Claassen
Journal:  J Sleep Res       Date:  2020-06-08       Impact factor: 3.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.